| Arming oncolytic reovirus with GM-CSF gene to enhance immunity V Kemp, DJM van den Wollenberg, MGM Camps, T van Hall, ... Cancer gene therapy 26 (9), 268-281, 2019 | 48 | 2019 |
| Exploring reovirus plasticity for improving its use as oncolytic virus V Kemp, RC Hoeben, DJM Van den Wollenberg Viruses 8 (1), 4, 2015 | 39 | 2015 |
| Simultaneous tumor and stroma targeting by oncolytic viruses A Everts, M Bergeman, G McFadden, V Kemp Biomedicines 8 (11), 474, 2020 | 36 | 2020 |
| miRNA repertoire and host immune factor regulation upon avian coronavirus infection in eggs V Kemp, A Laconi, G Cocciolo, AJ Berends, TM Breit, MH Verheije Archives of virology 165, 835-843, 2020 | 25 | 2020 |
| Developing oncolytic viruses for clinical use: A consortium approach V Kemp, MLM Lamfers, G Van Der Pluijm, BG van den Hoogen, ... Cytokine & growth factor reviews 56, 133-140, 2020 | 20 | 2020 |
| Oncolytic reovirus infection is facilitated by the autophagic machinery V Kemp, IJC Dautzenberg, RW Limpens, DJM Van den Wollenberg, ... Viruses 9 (10), 266, 2017 | 16 | 2017 |
| Nonhuman primate adenoviruses of the human adenovirus B species are potent and broadly acting oncolytic vector candidates STF Bots, V Kemp, SJ Cramer, DJM van den Wollenberg, M Hornsveld, ... Human Gene Therapy 33 (5-6), 275-289, 2022 | 13 | 2022 |
| N-glycosylation of infectious bronchitis virus M41 spike determines receptor specificity KM Bouwman, N Habraeken, A Laconi, AJ Berends, L Groenewoud, ... Journal of General Virology 101 (6), 599-608, 2020 | 13 | 2020 |
| Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus TJ Harryvan, M Golo, N Dam, MJA Schoonderwoerd, EA Farshadi, ... Cancer Gene Therapy 29 (12), 1918-1929, 2022 | 10 | 2022 |
| Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene V Kemp, IJC Dautzenberg, SJ Cramer, RC Hoeben, ... Gene Therapy 25 (5), 331-344, 2018 | 8 | 2018 |
| Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus ‘GoraVir’for the treatment of pancreatic ductal adenocarcinoma STF Bots, TJ Harryvan, C Groeneveldt, P Kinderman, V Kemp, ... Molecular Oncology 18 (5), 1245-1258, 2024 | 3 | 2024 |
| Preclinical evaluation of the gorilla-derived oncolytic adenovirus AdV-lumc007 “GoraVir” for the treatment of pancreatic ductal adenocarcinoma STF Bots, T Harryvan, C Groeneveldt, P Kinderman, V Kemp, ... Mol. Oncol, 2022 | 3 | 2022 |
| The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles K Vazaios, Ε Stavrakaki, LB Vogelezang, J Ju, P Waranecki, ... Molecular Therapy Oncology 32 (2), 2024 | 2 | 2024 |
| Genome Analyses of Ten New Ape Adenoviruses with Similarity to Human Mastadenovirus C STF Bots, V Kemp, IJC Dautzenberg, RC Hoeben International Journal of Molecular Sciences 23 (17), 9832, 2022 | 2 | 2022 |
| Evaluating the Effect of Intensity Standardisation on Longitudinal Whole Brain Atrophy Quantification in Brain Magnetic Resonance Imaging EE Carvajal-Camelo, J Bernal, A Oliver, X Lladó, M Trujillo, ... Applied Sciences 11 (4), 1773, 2021 | 2 | 2021 |
| Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures TE Schäfer, LI Knol, FV Haas, A Hartley, SCS Pernickel, A Jády, ... EBioMedicine 105, 2024 | 1 | 2024 |
| Advanced Therapy Medicinal Products: Clinical, Non-clinical, and Quality Considerations E Mastrobattista, E Doevendans, NP van Til, V Kemp, J de Vrij, ... Pharmaceutical Biotechnology: Fundamentals and Applications, 323-399, 2024 | 1 | 2024 |
| Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines DJM van den Wollenberg, V Kemp, MJWE Rabelink, RC Hoeben International Journal of Molecular Sciences 24 (3), 2320, 2023 | 1 | 2023 |
| Zeb1 downregulation sensitizes pancreatic cancer-associated fibroblasts to killing by oncolytic reovirus through upregulation of the reovirus receptor junction adhesion molecule A N Dam, TJ Harryvan, B Schmierer, LJAC Hawinkels, V Kemp Cancer Research 84 (6_Supplement), 2025-2025, 2024 | | 2024 |
| Oncolytic non-human adenoviruses and uses thereof RC Hoeben, B Selas, K Vera US Patent App. 17/625,483, 2022 | | 2022 |
